Scientific article
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)
Published in
Annals of oncology, vol. 11, no. 3, p. 301-306Publication date
2000Abstract
Keywords
- Adenocarcinoma/drug therapy/mortality/secondary
- Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use
- Cisplatin/administration & dosage/adverse effects
- Humans
- Paclitaxel/administration & dosage/adverse effects/analogs & derivatives
- Stomach Neoplasms/drug therapy/mortality/pathology
- Survival Analysis
- Taxoids
Note
Open Access - Licence nationale Oxford University PressUNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
ROTH, Arnaud et al. Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). In: Annals of oncology, 2000, vol. 11, n° 3, p. 301–306. doi: 10.1023/A:1008342013224
Main files (1)
Article (Published version)
Identifiers
- PID : unige:55288
- DOI : 10.1023/A:1008342013224
- PMID : 10811496
